MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Diagnosing Young-Onset and Familial Parkinson’s Disease Using an Extensive Targeted Panel

    HL. Chiang, YC. Lee (Taipei, Taiwan)

    Objective: To explore the diagnostic yield of a large PD-targeted panel that contains 85 genes in a Taiwanese cohort of young-onset and familial PD. Background:…
  • 2024 International Congress

    Understanding Parkinson’s disease in Spain: genetic and clinical insights

    M. Martín-Bornez, L. Muñoz-Delgado, R. Diaz-Belloso, MT. Periñán, M. Bonilla-Toribio, D. Buiza-Rueda, D. Macías-García, S. Jesús, A. Adarmes-Gómez, E. Ojeda, A. Luque-Ambrosiani, S. García-Díaz, R. Pineda, F. Carrillo, P. Mir, P. Gómez-Garre (Seville, Spain)

    Objective: The aim of this study was to investigate genetic variants associated with Parkinson's disease (PD) in a cohort of PD patients from southern Spain…
  • 2024 International Congress

    Novel ASO Targeting IGHMBP2 Cryptic Splice Variant: Efficacy and Safety

    S. Smieszek, B. Przychodzen, C. Tyner, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to target a specific cryptic splice site variant affecting immunoglobulin mu‐binding protein 2 (IGHMBP2) protein levels with a novel antisense oligonucleotide…
  • 2024 International Congress

    Neurodegeneration with brain iron accumulation in pediatric population: Clinico-radiologic and genetic features

    D. Kalikavil Puthanveedu, A. Cherian (Thiruvananthapuram, India)

    Objective: To correlate, clinical and magnetic resonance imaging (MRI) characteristics with genetics, of pediatric patients with Neurodegeneration with brain iron accumula­tion (NBIA). Background: NBIA is…
  • 2024 International Congress

    Spastic Ataxia and Motorneuron disease as possible manifestations of ATP13A2 (PARK 9) variants

    G. Dalla Zanna, A. Funcis, S. Rossi, F. Santorelli, M. Sabatelli, G. Silvestri (Rome, Italy)

    Objective: To describe 5 late-onset sporadic cases carrying either biallelic or monoallelic variants in ATP13A2, showing either spastic ataxia(Spatax) or primary lateral sclerosis (PLS) as…
  • 2024 International Congress

    Fatigue in PD is related to decreased efficiency of the frontal network

    SY. Kang, MS. Kim, S. Park, U. Park, SW. Kang (Hwaseong, Republic of Korea)

    Objective: We aimed to explore whether electroencephalography (EEG) could measure fatigue objectively and the pathophysiology of fatigue in PD. Background: Fatigue is a common, frustrating…
  • 2024 International Congress

    Non-invasive transcranial Eectrical Stimulation (tRNS and tACS) targeting the Pallidum in normal Controls and PD Patients by rotating electrical Fields

    Z. Soltaninejad, A. Szelenyi, A. Hunold, U. Fietzek, K. Ma, S. Goetz, A. Antal, A. Straube, W. Paulus (Munich, Germany)

    Objective: To identify if low intensity transcranial electric stimulation targeting the pallidum influences motor cortex excitability. Background: Low intensity electrical stimulation has been shown to…
  • 2024 International Congress

    Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

    R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)

    Objective: This project aimed to characterize the first-ever transgenic ATP13A2 knockout rat model to elucidate the underlying mechanisms of ATP13A2-associated pathology. Background: Most Parkinson’s disease…
  • 2024 International Congress

    Association Between Glycated Hemoglobin (HbA1c) Levels And Motor Symptoms In Indian Subjects With Parkinson’s Disease: A Cross Sectional Observational Study

    NIK. Choudhary, NAV. Seervi, AMI. Bhargava, SHU. K (Jodhpur, India)

    Objective: India is known for its diversity and genetic heterogeneity and our research seeks to fill the current gap in understanding how glycated hemoglobin (HbA1c)…
  • 2024 International Congress

    Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study

    V. van Midden, L. Strojnik, M. Mencin, N. Ogrinc, M. Kojović (Ljubljana, Slovenia)

    Objective: ​​​​​​To assess replicability of skin sebum volatile organic compound (VOC) composition 1) within the same subjects; 2) in frozen vs fresh samples, and 3)…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley